Details for New Drug Application (NDA): 021545
✉ Email this page to a colleague
The generic ingredient in PATADAY ONCE DAILY RELIEF is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 021545
| Tradename: | PATADAY ONCE DAILY RELIEF |
| Applicant: | Alcon Labs Inc |
| Ingredient: | olopatadine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 021545
| Mechanism of Action | Histamine H1 Receptor Antagonists |
| Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 021545
Suppliers and Packaging for NDA: 021545
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545 | NDA | Alcon Laboratories, Inc. | 0065-8150 | 0065-8150-01 | 1 BOTTLE, PLASTIC in 1 CARTON (0065-8150-01) / 2.5 mL in 1 BOTTLE, PLASTIC |
| PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545 | NDA | Alcon Laboratories, Inc. | 0065-8150 | 0065-8150-03 | 2 BOTTLE, PLASTIC in 1 CARTON (0065-8150-03) / 2.5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.2% BASE | ||||
| Approval Date: | Dec 22, 2004 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
